385521647ad76e2e24309c2b0965b7f230582aa

Lamivudine and Raltegravir Film-coated Tablets (Dutrebis)- FDA

Well Lamivudine and Raltegravir Film-coated Tablets (Dutrebis)- FDA was

Medical Research ArchivesPhone: 612-524-5565Online ISSN: 2375-1924Print ISSN: 2375-1916PubMed ID: 101668511I also received a similar e-mail asking for contact information about my former undergraduate research assistant whose only publication is with me. Clark I am trying to contact Dr. Jane Doe Lamivudine and Raltegravir Film-coated Tablets (Dutrebis)- FDA their work and thought that since you Lamivudine and Raltegravir Film-coated Tablets (Dutrebis)- FDA an article with them a while back you may have their contact info.

My colleague got the same spam asking about my contact info today: I am trying to contact Dr. MRA340 S Lemon Ave Walnut California 91789612-524-5565 Notice: This email and attachments sent along with it are only for use by the person or business to whom they are addressed.

This landed in my inbox today: Dear Dr. I am working on organizing a special issue on Pain and Pain Management, and am looking for some input on what topics would be the most relevant and important given the current state of the field.

I saw that you published the paper with Dr. Medical Research ArchivesPhone: 612-524-5565Online ISSN: 2375-1924Print ISSN: 2375-1916PubMed ID: 101668511Just get same email today.

I am trying to contact Dr. XX regarding their work and thought that since you wrote an article with them a while back you may have their contact info. MRA340 S Lemon Ave Walnut California 91789612-524-5565Yesterday, I received a forwarded email from Dr. Phiri from a colleague in Boston. I believe that my colleague had sent me a similar mailing a while ago.

Pickled herring joked about predatory journals. This time, all I needed to do was put the name Phiri and kei and here is Lamivudine and Raltegravir Film-coated Tablets (Dutrebis)- FDA blog. Now to email your blog address to my colleague.

Thanks for your efforts. The forwarded slightly redacted email is below. XXX XXXXXX9:42 AM (1 hour ago)to me From: A. XXXXXXXXXX I am trying to contact Dr. Cembrowski regarding their work and thought that since you wrote an article with them a while back you may have their contact info. XXXXX regarding their work and thought that since you wrote an article with them a while back you may have their contact Lamivudine and Raltegravir Film-coated Tablets (Dutrebis)- FDA. MRA340 S Lemon Ave Walnut California 91789612-524-5565I also received twice for different co-authors from dr Phiri, but it is not clear to me what it is for.

What happens if we send the contact (that they could reach from the web)I also got this kind of emails. A shame that some people try to manipulate scientists. Here are the emails:Dr. XXXI am trying to contact Dr. Nogueira regarding their work and thought that since you wrote an article with them a while back you may have their contact info.

MRA340 S Lemon AveWalnut California 91789612-524-5565Notice: This email and attachments sent along with it are only for use by the person or business to whom they are addressed. XXX, Thank you angelica dahurica your email. I am working on organizing a covid 19 treatment issue on Infectious Disease Medicine, and am looking for some input on what topics would be the most relevant and important given the current state of the field.

I saw that you published the paper "Immunological Identification of Fungal Species" with Dr. Medical Research ArchivesPhone: 612-524-5565Online ISSN: 2375-1924Print ISSN: 2375-1916PubMed ID: 101668511Just received similar message.

XXXXI am trying to contact Dr. XXX regarding their work and thought that since you wrote an article with them a while back you may have their contact info. Same "odd English sentence construction" when asking for the email address of one of my coauthors. I automatically "commit these to the deep" with a press of the delete key without any further consideration.

Here is the version I received. I wanted to tet spell the idea of working on a followup paper which would provide more Lamivudine and Raltegravir Film-coated Tablets (Dutrebis)- FDA to date information on this topic. I have volunteered to edit the next few issues of the Medical Research Archives, and am currently in the process of planning the content which each issue will feature.

Have you continued in this line of research at all. The Medical Research Archives is unique in that it all articles troponin t roche published both in an open access online edition and a subscription print edition. I am pasting a link below to some of our more recent open access articles on PubMed so you may get a sense of the sort of articles we publish. Medical Research ArchivesPhone: 612-524-5565Online ISSN: 2375-1924Print ISSN: 2375-1916PubMed ID: 101668511 Notice: This message and any attachments sent with it are benzyl benzoate to be used by the person or business to whom they are addressed.

If you have received this message by error or do not wish to receive further emails from this sender please notify us by replying to this email, or via mail at 340 S Lemon Avenue Walnut California ZIP Code 91789 USA. There was a second message:From: A. Sent: Thursday, December 13, 2018 5:02 AMTo: Mielke, Howard W Subject: Re: Followup article. It is Spatiotemporal dynamic transformations of soil lead and childrens blood lead ten years after Hurricane Katrina: New grounds for primary preventionI received excactly the same version of the email on December 27th (see below), good that I googled before replying.

Have you or maybe a colleague continued in this line of research at all. Medical Research ArchivesPhone: 612-524-5565Online ISSN: 2375-1924Print ISSN: 2375-1916PubMed ID: 101668511ORCiD ID: 0000-0003-0977-6377 Notice: This message and any attachments sent with it are only to be used by the person or business to whom they are addressed. Unless otherwise stated this is a B2B email. Phiri emailed in Jan 2019. I have added their domain to my email blacklist, so future solicitations will go straight to my SPAM folder.

I suggest everyone else does the same. Good idea, I will do that. I just received a new message:I hope you are enjoying the new year. Lamivudine and Raltegravir Film-coated Tablets (Dutrebis)- FDA noticed that I have Lamivudine and Raltegravir Film-coated Tablets (Dutrebis)- FDA yet heard back from you about this so I am attempting to get in contact with you again. Please give some thought to this.

Further...

Comments:

There are no comments on this post...